Literature DB >> 20875105

Effects of Sophora japonica flowers (Huaihua) on cerebral infarction.

Hsiang-Ni Chen1, Ching-Liang Hsieh.   

Abstract

The dried flowers and buds of Sophora japonica are used as a medicinal herb in China, Japan and Korea to treat bleeding hemorrhoids and hematemesis. This article presents an overview of the effects of Sophora japonica on cerebral infarction based on literature searched from Medline, PubMed, Cochrane Library and the China National Knowledge Infrastructure (CNKI). Sophora japonica contains both anti-hemorrhagic and anti-hemostatic substances. Sophora japonica reduces cerebral infarction partly as a result of its anti-oxidative and anti-inflammatory activities. Previous studies found that Sophora japonica reduced the size of cerebral infarction and neurological deficits and reduced microglial activation, interleukin-1β release and number of apoptotic cells in ischemia-reperfusion injured Sprague-Dawley rats. Further study is required to determine the relationship between Sophora japonica-mediated reduction in cerebral infarction size and the effects of Sophora japonica on platelet aggregation and cardiovascular function.

Entities:  

Year:  2010        PMID: 20875105      PMCID: PMC2954919          DOI: 10.1186/1749-8546-5-34

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


Background

Dried flowers and buds of Sophora japonica (Huaihua) are a medicinal herb used in China, Japan and Korea to treat hemorrhoids and hematemesis [1]. Main components of Sophora japonica include flavones, tetraglycosides, isoflavones, isoflavone tetraglycosides, triterpene glycosides, phospholipids, alkaloids, amino acids and polysaccharides [2]. Moreover, Sophora japonica contains five main flavonoids of rutin, quercetin, isorhamnetin, isorhamnetin, genistein and kaempferol [2]. This article aims to provide an overview of the pharmacology of Sophora japonica, in particular its effects and mechanisms in reducing cerebral infarction (Table 1). To this end, we searched the English language databases namely Medline, PubMed, Cochrane Library and Chinese language database namely China National Knowledge Infrastructure (CNKI) between 1980 and 2009, using Sophora japonica (OR quercetin OR rutin) AND cerebral infarction as the English keywords and Huaihua as the Chinese one. The initial search generated 173 articles from the English language databases and 141 articles from the Chinese one.
Table 1

Possible pharmacological actions of Sophora japonica on cerebral infarction

Pharmacological actionsRelated componentsPossible mechanisms
Anti-oxidative effectsflavonoidscavenges superoxide anion and free radicals [8]
polysaccharidesscavenges hydroxyl and superoxide anion free radicals [9]
quercetin and rutinscavenge free radicals [10]
rutininhibits the conversion of superoxide anion to hydroxyl radicals[11]
irisolidoneinhibits lipid peroxidation, DNA damage, and reduced apoptosis induced by hydrogen peroxide[12]
Anti-inflammatory effectsquercetin and rutininhibit microglial activation, interleukin-1β (IL-1β) release, and apoptosis [25]
rutinreduce IL-1β mRNA expression [26]
Anti-platelet aggregation effectsbiochanin A, irisolidone, genistein and tectoridininhibit arachidonic acid- and thromboxane A2- induced platelet aggregation [2]
quercetininhibits free calcium increase within platelets [27]
Cardiovascular effectsSophora japonica decoctionreduces cardiac muscle contractility and reduces heart rate [30,31]
Quercetinstabilizes capillary integrity [32]
rutin, quercetin and tanninreduce capillary perameability [31,33]
Isorhamnetinincreases capillary permeability [1]
Possible pharmacological actions of Sophora japonica on cerebral infarction

Pharmacology

Anti-oxidative effects

Our previous studies found that (1) levels of superoxide anion in arterial blood increased at the start of 2 hours of reperfusion after ischemia in rats with middle cerebral artery occlusion (MCAo) [3]; (2) levels of superoxide anion in the region of brain parenchymal damage increased during 2 hours of reperfusion after cerebral ischemia in ischemia-reperfusion injured rats [4]; (3) Guizhifuling Wan (consisting of Cinnamon twig, Prunus persica [L] Batsch, Poria cocos [Schw.] Wolf, Paeonia lactiflora Pall, Paeonia suffruticosa Andr, Angelica sinensis [Oliv. Diels and Ligusticum chuanxiong Hort.] with ferulic acid and Paeonia suffruticosa with paeonol as components and the root of Paeonia lactflora Pall) reduced superoxide anion levels during 2 hours of reperfusion after ischemia, cerebral infarction size and neurological deficit score in rats with MCAo [3-5]. Free radical scavenging activity was demonstrated in Ginkgo biloba L. leaves which contain quercetin and rutin which have free radical scavenging activity [6]. Extracts of Ginkgo biloba L. leaves (Egb 761) reduced the size of cerebral infarction and improved neurological behavior in rats with permanent and transient MCAo [7]. Ma et al. found that the flavonoid components of Sophora japonica scavenged superoxide anion and 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radicals [8]. Simple and orthogonal experiments to study the antioxidative activites of Sophora japonica, Wang et al. found that the polysaccharides of Sophora japonica scavenged hydroxyl and superoxide anion free radicals [9]. Both quercetin and rutin demonstrated free radical scavenging activity; however, quercetin offered better protection. A study reported that quercetin (better than rutin) protected rabbit erythrocytes with normal and high cholesterol content against lipid peroxidation by t-BuOOH-induced reactive oxygen species [10]. Afanas'ev et al. found that rutin in iron-rutin complex inhibited the conversion of superoxide anion to hydroxyl radicals in normal and iron-overloaded rats [11]. Kang et al. showed that the anti-oxidant irisolidone prevented lipid peroxidation, DNA damage and reduced apoptosis induced by hydrogen peroxide in Chinese hamster lung fibroblasts [12]. Generation of reactive oxygen species (ROS) including nitrogen and oxygen free radicals played a critical role in brain damage during the reperfusion period after ischemia [13,14]. Brain damage due to ROS-mediated injury involved metabolic signal transmission among mitochondria, DNA repair enzymes and transcription factors leading to apoptosis [15]. Anti-oxidant components such as those in Gingko biloba extracts played a neuroprotective role [16,17]. Both quercetin and rutin scavenged free radicals, improved spatial memory and reduced neuronal death induced by repeated cerebral ischemia [18]. Rutin reduced ischemia-reperfusion injury by scavenging reactive species [14,19].

Anti-inflammatory effects

Microglia was activated by various types of brain damage such as ischemic and inflammatory damage [20]. This activation indicated the severity of neuronal damage in rats with MCAo [21]. The levels of IL-1β, a pro-inflammatory cytokine which is expressed mainly by glial cells such as astrocytes, oligodendrocytes and microglia [22] increased after permanent focal cerebral ischemia [23] whereas they reduced leucocyte infiltration, thereby causing neuronal damage and brain edema [24]. Similarly, our previous studies found that both Guizhifuling Wan and paeonol inhibited microglial activation and IL-1β release and reduced cerebral infarction size in rats with MCAo [3,5]. Sophora japonica inhibited microglial activation, interleukin-1β (IL-1β) release and apoptosis in rats with transient MCAo, suggesting that Sophora japonica reduced inflammation and prevented neuronal death by inhibiting microglial release of IL-1β, a pro-inflammatory cytokine [25]. Koda et al. reported that dietary rutin supplementation 10 or 20 days after trimethyltin (TMT) administration in rats reduced IL-1β mRNA expression in the microglia of the hippocampus, suggesting that rutin was neuro-protective against TMT-induced neuronal damage [26].

Anti-platelet aggregation effects

Kim and Yun-Chol reported that, compared with acetylsalicylic acid, biochanin A, irisolidone, genistein and tectoridin of Sophora japonica were stronger inhibitors of arachidonic acid- and thromboxane A2-induced platelet aggregation in platelet-rich and platelet-poor plasma in rats [2]. A study found that quercetin of Sophora japonica inhibited free calcium accumulation within platelets thereby preventing platelet aggregation [27]. Antiplatelet agents such as aspirin were recommended for the treatment of acute ischemic stroke [28]. Platelet adhesion was enhanced after MCAo and reperfusion in mice [29].

Effects on cardiovascular system and blood coagulation

Administration of Sophora japonica decoction into the jugular veins of rabbits decreased cardiac muscle contractility and reduced heart rate, suggesting that Sophora japonica reduced the consumption of oxygen to protect cardiac function [30,31]. The anti-hemorrhagic effect of quercetin (water extracts of the buds of Sophora japonica) was due to stabilization of capillary integrity [32]. Oral administration of Sophora japonica extracts (containing rutin, quercetin and tannin) for five days reduced capillary perameability, bleeding time and coagulation time in mice and reduced prothrombin time in rats, thereby demonstrating the hemostatic effect of Sophora japonica [30,33]. Isorhamnetin from Sophora japonica was also anti-hemostatic, as a result from increased capillary permeability and reduced platelet aggregation [1].

Conclusion

Sophora japonica contains both anti-hemorrhagic and anti-hemostatic substances. Sophora japonica reduces cerebral infarction partly as a result of its anti-oxidative and anti-inflammatory activities. Further study is required to determine the relationship between Sophora japonica-mediated reduction in cerebral infarction size and its effects on platelet aggregation and cardiovascular function.

Abbreviations

MCAO: middle cerebral artery occlusion; EGB 761: extract of Ginkgo biloba L. leaves; DPPH: 1,1-diphenyl-2-picrylhydrazyl; T-BUOOH: tert-butyl hydroperoxide; IL-1β: interleukin-1β; TMT: trimethyltin; MRNA: messenger ribonucleic acid; ROS: reactive oxygen species; DNA: deoxyribonucleic acid

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CLH designed the study and revised the manuscript. HNC conducted the literature search and drafted the manuscript. Both authors read and approved the final version of the manuscript.
  27 in total

1.  Membrane cholesterol contents influence the protective effects of quercetin and rutin in erythrocytes damaged by oxidative stress.

Authors:  Abel López-Revuelta; José I Sánchez-Gallego; Angel Hernández-Hernández; Jesús Sánchez-Yagüe; Marcial Llanillo
Journal:  Chem Biol Interact       Date:  2006-03-12       Impact factor: 5.192

2.  Studies on antihemorrhagic substances in herbs classified as hemostatics in Chinese medicine. VI. On the antihemorrhagic principle in Sophora japonica L.

Authors:  H Ishida; T Umino; K Tsuji; T Kosuge
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-02       Impact factor: 1.645

Review 3.  Reactive oxygen radicals in signaling and damage in the ischemic brain.

Authors:  P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-01       Impact factor: 6.200

4.  The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia.

Authors:  T Morioka; A N Kalehua; W J Streit
Journal:  J Cereb Blood Flow Metab       Date:  1991-11       Impact factor: 6.200

5.  Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats.

Authors:  Ching-Liang Hsieh; Chin-Yi Cheng; Tung-Hu Tsai; I-hsin Lin; Chung-Hsiang Liu; Su-Yin Chiang; Jaung-Geng Lin; Chih-Jui Lao; Nou-Ying Tang
Journal:  J Ethnopharmacol       Date:  2006-02-03       Impact factor: 4.360

6.  Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia.

Authors:  Yasemin Gürsoy-Ozdemir; Alp Can; Turgay Dalkara
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

7.  Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats.

Authors:  E-Jian Lee; Hung-Yi Chen; Tian-Shung Wu; Tsung-Ying Chen; Issam A Ayoub; Kenneth I Maynard
Journal:  J Neurosci Res       Date:  2002-06-01       Impact factor: 4.164

8.  Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion.

Authors:  Satoshi Terao; Gokhan Yilmaz; Karen Y Stokes; Janice Russell; Mami Ishikawa; Takeshi Kawase; D Neil Granger
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

9.  Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury.

Authors:  Ram Gupta; Manjeet Singh; Ajay Sharma
Journal:  Pharmacol Res       Date:  2003-08       Impact factor: 7.658

10.  Microglial response to transient focal cerebral ischemia: an immunocytochemical study on the rat cerebral cortex using anti-phosphotyrosine antibody.

Authors:  K Korematsu; S Goto; S Nagahiro; Y Ushio
Journal:  J Cereb Blood Flow Metab       Date:  1994-09       Impact factor: 6.200

View more
  4 in total

1.  A randomized, double-blind, placebo-controlled trial of a Chinese herbal Sophora flower formula in patients with symptomatic haemorrhoids: a preliminary study.

Authors:  Kee-Ming Man; Wen-Chi Chen; Hwei-Ming Wang; Huey-Yi Chen; Jui-Lung Shen; Lieh-Der Chen; Fuu-Jen Tsai; Yung-Hsiang Chen; De-Xin Yu; Feng-Fan Chiang
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

2.  Anti-inflammatory effects of Chinese medicinal herbs on cerebral ischemia.

Authors:  Shan-Yu Su; Ching-Liang Hsieh
Journal:  Chin Med       Date:  2011-07-09       Impact factor: 5.455

3.  The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs.

Authors:  Emily Guzman; Jeanmaire Molina
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

4.  Protective Effects of Naringin in Cerebral Infarction and Its Molecular Mechanism.

Authors:  Jinping Yang; Lei Yuan; Ying Wen; Haiyan Zhou; Wenhan Jiang; Dan Xu; Minling Wang
Journal:  Med Sci Monit       Date:  2020-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.